Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA060158-09
Application #
2100817
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1993-05-01
Project End
1997-02-28
Budget Start
1996-03-01
Budget End
1997-02-28
Support Year
9
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
University of Florida
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611

  Publications

Schneider-Berlin, Kristen R; Bonilla, Tonya D; Rowe, Thomas C (2005) Induction of petite mutants in yeast Saccharomyces cerevisiae by the anticancer drug dequalinium. Mutat Res 572:84-97
St Pierre, Jason; Wright, David J; Rowe, Thomas C et al. (2002) DNA topoisomerase II distribution in mouse preimplantation embryos. Mol Reprod Dev 61:335-46
St Pierre, Jason; Wright, David J; Rowe, Thomas C et al. (2002) DNA topoisomerase II is essential for preimplantation mouse development. Mol Reprod Dev 61:347-57
Rowe, T C; Grabowski, D; Ganapathi, R (2001) Isolation of covalent enzyme-DNA complexes. Methods Mol Biol 95:129-35
Schneider Berlin, K R; Ammini, C V; Rowe, T C (1998) Dequalinium induces a selective depletion of mitochondrial DNA from HeLa human cervical carcinoma cells. Exp Cell Res 245:137-45
Weissig, V; Lasch, J; Erdos, G et al. (1998) DQAsomes: a novel potential drug and gene delivery system made from Dequalinium. Pharm Res 15:334-7